In our previous report, we demonstrated that ENO1 cell surface expression is important for plasminogen-dependent invasion, and that targeting of ENO1 with a monoclonal antibody inhibits the invasiveness of pancreatic cancer cells [12]. The gene discussed is PLG; the disease is familial pancreatic carcinoma.